RNCP Portfolio-Wide Dosimetry Verification Services
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Tom Bahrami tom.bahrami@nih.gov
- Andrea Dicarlo-Cohen andrea.dicarlo-cohen@nih.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The National Institutes of Health (NIH) is forecasting a new requirement for RNCP Portfolio-Wide Dosimetry Verification Services, targeting research and development in biotechnology. The contract, with an estimated award date of December 1, 2024, falls under NAICS code 541714 for biotechnology research and development. The opportunity is not set aside for any specific category of business.
While specific award values and detailed service quantities are not provided, the contract involves dosimetry verification services across the RNCP portfolio. Key points of contact include Andrea Dicarlo-Cohen, RNCP Director at the National Institute of Allergy and Infectious Diseases, and Tom Bahrami, both representing the National Institutes of Health. Interested vendors can reach out to Andrea Dicarlo-Cohen at andrea.dicarlo-cohen@nih.gov for potential additional information about this federal contract opportunity.
Forecast text
RNCP Portfolio-Wide Dosimetry Verification Services
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast